MY113797A - 14alpha, alpha 17 -c2-bridged norprogesterone derivatives - Google Patents

14alpha, alpha 17 -c2-bridged norprogesterone derivatives

Info

Publication number
MY113797A
MY113797A MYPI95004075A MYPI19954075A MY113797A MY 113797 A MY113797 A MY 113797A MY PI95004075 A MYPI95004075 A MY PI95004075A MY PI19954075 A MYPI19954075 A MY PI19954075A MY 113797 A MY113797 A MY 113797A
Authority
MY
Malaysia
Prior art keywords
stands
hydrogen atom
alkyl radical
hydrogen
stand
Prior art date
Application number
MYPI95004075A
Inventor
Hans-Peter Muhn Dr
Klaus Schollkopf Dr
Karl-Heinrich Fritzemeier Dr
Wolfgang Schwede Dr
Wolfgang Halfbrodt Dr
Rolf Krattenmacher Dr
Joachim Kuhnke Dr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MY113797A publication Critical patent/MY113797A/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

THE INVENTION DESCRIBES 14,17-C2-BRIDGED STEROIDS OF GENERAL FORMULA (I), IN WHICHR3 STANDS FOR AN OXYGEN ATOM, THE HYDROXYIMINO GROUP OR TWO HYDROGEN ATOMS,R6 STANDS FOR A HYDROGEN, FLUORINE, CHLORINE OR BROMINE ATOM OR R6 STANDS FOR A C1-C4 ALKYL RADICAL IN A- ORb-POSITION, AND THEN R6'' AND R7 REPRESENT HYDROGEN ATOMS, OR ELSER6'' STANDS FOR A HYDROGEN, FLUORINE, CHLORINE OR BROMINE ATOM OR R6'' STANDS FOR A C1-C4 ALKYL RADICAL, AND THENR6'' AND R7 REPRESENT A COMMON ADDITIONAL BOND, R7 STANDS FOR A C1-C4 ALKYL RADICAL IN a - OR b-POSITION, AND THEN R6 AND R6'' REPRESENT HYDROGEN ATOMS, OR ELSER6 AND R7 TOGETHER STAND FOR A METHYLENE GROUP IN a- OR b- POSITION AND R6'' STANDS FOR A HYDROGEN ATOM ORR6 AND R6'' TOGETHER STAND FOR AN ETHYLENE OR METHYLENE GROUP, AND R7 STANDS FOR A HYDROGEN ATOM,R11 AND R12 EACH STAND FOR A HYDROGEN ATOM OR A COMMON BOND,R13 STANDS FOR A METHYL OR ETHYL GROUP,RI5 STANDS FOR A HYDROGEN ATOM OR A C1-C3 ALKYL RADICAL,R16 AND R16'' , INDEPENDENTLY OF ONE ANOTHER, STAND FOR A HYDROGEN ATOM, A C1-C3 ALKYL RAD<CAL OR A C2-C4 ALKENYL RADICAL OR TOGETHER FOR A C1-C3 ALKYLIDENE GROUP,R15 AND R16 STAND FOR A COMMON BOND AND R16'' STANDS FOR A HYDROGEN ATOM OR A C1-C3 ALKYL RADICAL ORR15 AND R16 TOGETHER STAND FOR A RING OF PARTIAL FORMULA IN WHICH N = 1 AND 2 AND X MEANS A METHYLENE GROUP OR AN OXYGEN ATOM, AND RI6'' STANDS FOR A HYDROGEN ATOM,R171 STANDS FOR A HYDROGEN ATOM OR A C2-C3 ALKYL RADICAL,R172 STANDS FOR A HYDROGEN ATOM, A C2-C3 ALKYL RADICAL OR A C2-C4 ALKENYL RADICAL,
MYPI95004075A 1994-12-23 1995-12-23 14alpha, alpha 17 -c2-bridged norprogesterone derivatives MY113797A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4474016 1994-12-23

Publications (1)

Publication Number Publication Date
MY113797A true MY113797A (en) 2002-05-31

Family

ID=81534527

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI95004075A MY113797A (en) 1994-12-23 1995-12-23 14alpha, alpha 17 -c2-bridged norprogesterone derivatives

Country Status (1)

Country Link
MY (1) MY113797A (en)

Similar Documents

Publication Publication Date Title
BG103603A (en) Antigestagene steroids with fluorinated 17 alpha-alkyl chain
EP1207155A4 (en) Drug compositions exhibiting thrombopoietin agonism
MX9805181A (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives.
TR199701105T1 (en) � midazo (1,2-a) pyridin t � revleri.
HUP0203575A2 (en) Pharmaceutical compositions containing th2 differentiation inhibitors and their use
MY117671A (en) Use of low-volatility pyrazole derivatives having hydrophilic groups as nitrification inhibitors
ZA924787B (en) 4-pyrimidinecarboxamide derivatives,their preparation and their application in therapy
IT1255802B (en) IMIDAZOLIC DERIVATIVES FOR ACTIVITY A II ANTAGONIST
CA2449679A1 (en) Androstenones
AR007108A1 (en) ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS.
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
MX9605458A (en) Amide derivatives and their therapeutic use.
IL90309A0 (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
WO1996020209A3 (en) 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
IL98488A0 (en) Oxazole derivatives,their preparation and pharmaceutical compositions containing them
DK0885004T3 (en) Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives as NMDA receptor subtype blockers
HU9202100D0 (en) New 16-methyl-pregna-1,4-diene-3,20-dione derivatives
CA2416311A1 (en) 16alpha-methyl or ethyl substituted estrogens
PL359238A1 (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
DK1200442T3 (en) Derivatives of 2,3-benzodiazepine
FR2708604A1 (en) Use of benzenesulphonylindole (phenylsulphonylindole) derivatives for the preparation of medicaments
FI932446A0 (en) 2b, 19-methylaminobrosteroid with an aromatase inhibitor
MX9707672A (en) Azole compounds with antimycotic activity for human and veterinary use.
MX9707006A (en) 17-difluoromethylene-oestratrienes.
MX9802679A (en) Dithiolan derivatives, their preparation and their therapeutic effect